Renal Physiology for the Boards – Melanie P. Hoenig, MD
Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD
Question and Answer Session – Faculty
Renal Pathology in 2021: Part 1 Nephritic Conditions – Helmut G. Rennke, MD
Renal Pathology in 2021: Part 2 – Astrid Weins, MD, PhD
Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MD
Question and Answer Session – Faculty
IgA Nephropathy – Gerald B. Appel, MD
Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD
ANCA Vasculitis – John L. Niles, MD
Question and Answer Session – Faculty
Update on Lupus Nephritis – Gerald B. Appel, MD
Metabolic Management of Kidney Stones – Gary C. Curhan, MD, ScD
Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
Question and Answer Session – Faculty
Glomerulonephritis: Questions & Answers Session – Gerald B. Appel, MD
Must-Know Clinical Images in Nephrology – Ajay K.. Singh, MBBS, FRCP (UK), MBA
Must-Know Board Zebras – Emily S. Robinson, MD, MPH
Nephrology Board Review Practice 1 – Finnian R. McCausland, MB BCh, MMSc, FRCPI
Nephrology Board Review Practice 2 – Mallika Mendu, MD, MBA
Hyponatremia and Hypernatremia – Sodium Disorders – David B. Mount, MD
Hypokalemia and Hyperkalemia – Potassium Disorders – David B. Mount, MD
Question and Answer Session – Faculty
Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir
Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, BChir
Question and Answer Session – Faculty
Pregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH
Treating Renal Patients with Rituximab in the Era of COVID-19 – David B. Mount, MD
Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
Update on Polycystic Kidney Disease – Cristian Riella, MD
Question and Answer Session – Faculty
Pediatric Nephrology – Michael J.G. Somers, MD
Genetics: How to Integrate It into Practice – Ali Gharavi, MD
Social Determinants/Disparities in Renal Disease – Winfred W. Williams, Jr., MD
Question and Answer Session – Faculty
Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, BChir
Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, BChir
Chronic Kidney Disease in the Community: Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP
SPECIAL LECTURE — End-Stage Renal Disease in Areas of Armed Conflict: Challenges and Solutions – Sahar Koubar, MD
Why Do We Reject a Transplant? – Jamil R. Azzi, MD
Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
Question and Answer Session – Faculty
Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD
Early Post-Transplant Management – Anil K. Chandraker, MD
Question and Answer Session – Faculty
Evaluation of the Kidney Living Donor – Kassem Safa, MD
Late Loss of the Kidney Transplant – Andrew M. Siedlecki, MD
Infections in Transplant Recipients – Sarah P. Hammond, MD
Monitoring Kidney Transplant Patients: Beyond Creatinine – Saif Abdulkarim Muhsin, MB BCh
Pre-Transplant Surgical Evaluation of Recipients – Jamil R. Azzi, MD
Question and Answer Session – Faculty
Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD
Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD
Geriatric Nephrology – Ernest I. Mandel, MD
COVID-19 Vaccination Response in Transplant Patients – Ann Woolley, MD
Immunologic Basis of Kidney Disease – Vivek Kasinath, MD
Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD
Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD
Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD
Transplant Board Review – Anil K. Chandraker, MD
Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh
Management of Hypertension after SPRINT – Richard J. Glassock, MD
Question and Answer Session – Faculty
Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc
Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI
Liver and the Kidney – Andrew S. Allegretti, MD, MSc
Question and Answer Session – Faculty
Update on Renovascular Disease – Joseph M. Garasic, MD
Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
Acute Kidney Injury Syndromes – Alice M. Sheridan, MD
ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh
Question and Answer Session – Faculty
Cancer and Acute Kidney Injury – Albert Q. Lam, MD
Paraprotein Induced Kidney Injury – Albert Q. Lam, MD
FSGS: A Lesion, Not a Disease – Richard J. Glassock, MD
Interstitial Nephritis: Overview for the Boards – Julie M. Paik, MD, ScD, MPH
APOL1 and Kidney Disease – Martin R. Pollak, MD
Question and Answer Session – Faculty
Dialysis Dosing – J. Kevin Tucker, MD
Mineral and Bone Disease – David Bushinsky, MD
Question and Answer Session – Faculty
Dialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
Pearls in Mineral and Bone Disease – David Bushinsky, MD
Chronic Kidney Disease Epidemiology: A 2021 Update – Gearoid M. McMahon, MB BCh
Question and Answer Session – Faculty
Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC
COVID-19 and Kidney Disease – Daniel Batlle, MD
Mesoamerican Nephropathy – Ricardo Correa-Rotter, MD
Dialysis Vascular Access: Assessment and Complications – Dirk M. Hentschel, MD
Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
Question and Answer Session – Faculty
